Martin-Valls, Gerard Eduard
Li, Yanli
Clilverd, Hepzibar
Soto, Jordi
Cortey, Martí
Mateu, Enric
Funding for this research was provided by:
Laboratori Veterinari de Diagnosi de Malalties Infeccioses (Own funds)
Boehringer Ingelheim (Boehringer Ingelheim European PRRS Research Award)
Article History
Received: 12 March 2023
Accepted: 10 October 2023
First Online: 20 October 2023
Declarations
:
: The present study was approved by the Commission on Ethics in Human and Animal Experimentation of the Universitat Autònoma de Barcelona, project n° 3361, procedure n° 5709. All methods and procedures were performed in accordance with European Union Directive 2010/63/EU. Participating farms were informed of the study and consented to participate.
: EM has carried out several research contracts with companies in the pharmaceutical sector that manufacture vaccines against PRRSV. None of them participated in this study nor have they participated in the design of the study, selection of farms, taking of samples, obtaining results, data analysis, data interpretation, writing of the document or discussion of the results. All the other authors declare no competing interests.
: Not applicable.